137
Participants
Start Date
February 28, 2013
Primary Completion Date
October 31, 2016
Study Completion Date
January 31, 2017
Pregabalin
At the 4-week dose-titration phase, will receive one capsule of pregabalin (75 mg) twice daily from Day 1 to Day 7, and two capsules of pregabalin (150 mg) twice daily from Day 8 to Day 14. From Day 15 to Day 28, patients will perform dosage adjustments based on the pain relief and tolerability. At maintenance phase, patients will take the optimized dosage of pregabalin.
Placebo
At the 4-week dose-titration phase, will receive one capsule of placebo twice daily from Day 1 to Day 7, and two capsules of placebo twice daily from Day 8 to Day 14. From Day 15 to Day 28, patients will perform dosage adjustments based on the pain relief and tolerability. At maintenance phase, patients will take the optimized dosage of placebo.
Cancer Center of Sun Yat-sen University, Guangzhou
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou
Guangzhou Huiai Hospital, Guangzhou
Zengcheng People's Hospital, Guangzhou
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER